CR
CRISPR Therapeutics
CRSP·NASDAQZug CHFounded 2013800 employees
Mid CapbiotechPublicGenetic MedicineHematology
Platform: CRISPR
Market Cap
$4B
All Drugs
3
Clinical Trials
3
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (CRSP)
Loading CRSP stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| CRS-6525 | CRS-6525 | Phase 2 | 1 | CD20 | Ovarian CaAlzheimer's | ||
| CRS-337 | CRS-337 | Phase 2/3 | 1 | PARP | PVPTSD | ||
| CRS-184 | CRS-184 | Phase 1/2 | 1 | AHR | PompeMelanoma |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)